{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T09:33:51Z","timestamp":1776332031964,"version":"3.50.1"},"reference-count":14,"publisher":"Informa Healthcare","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1185\/030079908x253762","type":"journal-article","created":{"date-parts":[[2009,4,14]],"date-time":"2009-04-14T14:41:07Z","timestamp":1239720067000},"page":"267-274","source":"Crossref","is-referenced-by-count":20,"title":["Clopidogrel versus aspirin in patients with atherothrombosis: CAPRIE-based calculation of cost-effectiveness for Germany"],"prefix":"10.1185","volume":"24","author":[{"given":"K.","family":"Berger","sequence":"first","affiliation":[{"name":"University Hospital Munich\rDepartment of Hemostaseology and Transfusion MedicineEconomic Working Group\rZiemssenstrasse 1, D-80336 MunichGermany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Hessel","sequence":"additional","affiliation":[{"name":"Health Economics Outcomes Research, Sanofi-Aventis Pharma GmbH\rBerlinGermany"},{"name":"Institute for Health Care Management, University of Duisburg-Essen\rEssenGermany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kreuzer","sequence":"additional","affiliation":[{"name":"St. Vincenz-Hospital Limburg\rDepartment of Cardiology, LimburgGermany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Smala","sequence":"additional","affiliation":[{"name":"MERG \u2013 Medical Economics Research Group\rMunichGermany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.C.","family":"Diener","sequence":"additional","affiliation":[{"name":"University Hospital Essen, Neurological Clinic and Policlinic\rEssenGermany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2007,12,4]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2004.00177.x"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)09457-3"},{"key":"CIT0006","first-page":"270","volume":"5","author":"Schellinger PD","year":"2004","journal-title":"The value of platelet inhibitors in secondary prophylaxis of stroke \u2013 a review. Fortschr Neurol Psychiatr"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1007\/s10389-005-0112-3"},{"key":"CIT0008","first-page":"55","volume":"6","author":"Annemans L","year":"2003","journal-title":"JME"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/S1098-3015(10)61273-9"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7426.1267"},{"key":"CIT0012","first-page":"627","volume":"5","author":"Caro JJ","year":"2004","journal-title":"Migliaccio-Walle K. Estimating survival for cost-effectiveness analyses: a case study in atherothrombosis. Value Health"},{"key":"CIT0013","first-page":"216","volume":"13","author":"Br\u00fcggenj\u00fcrgen B","year":"2005","journal-title":"Cost of atherothrombotic diseases \u2013 myocardial infarction (MI), ischaemic stroke (IS) and peripheral arterial occlusive disease (PAD). J Public Health"},{"key":"CIT0016","first-page":"937","volume":"24","author":"Hense HW","year":"2003","journal-title":"Framingham risk function overestimates risk of coronary heart disease in men and women from Germany \u2013 results from the MONICA Augsburg and the PROCAM cohorts. Eur Heart J"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1007\/BF03044983"},{"key":"CIT0020","first-page":"797","volume":"12","author":"Schleinitz MD","year":"2004","journal-title":"Owens DK. Clopidogrel versus aspirin for secondary prophylaxis of vascular events: a cost-effectiveness analysis. Am J Med"},{"key":"CIT0021","first-page":"568","volume":"6","author":"Caro JJ","year":"1999","journal-title":"CAPRA (CAPRIE Actual Practice Rates Analysis) Study Group. Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events. Am J Med"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1177\/027298902320556118"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/030079908X253762","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T17:43:45Z","timestamp":1536601425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1185\/030079908X253762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,4]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2007,11,16]]},"published-print":{"date-parts":[[2008,1]]}},"alternative-id":["10.1185\/030079908X253762"],"URL":"https:\/\/doi.org\/10.1185\/030079908x253762","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,4]]}}}